Get the Stockscreener App
25.28
2.31%
0.57
Brainsway Ltd Adr stock is traded at $25.28, with a volume of 95,651.
It is up +2.31% in the last 24 hours and up +30.51% over the past month.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
See More
Previous Close:
$24.71
Open:
$25.38
24h Volume:
95,651
Relative Volume:
1.14
Market Cap:
$498.65M
Revenue:
$38.63M
Net Income/Loss:
$1.50M
P/E Ratio:
268.08
EPS:
0.0943
Net Cash Flow:
$5.97M
1W Performance:
+14.23%
1M Performance:
+30.51%
6M Performance:
+115.52%
1Y Performance:
+141.45%
1-Day Range:
$24.19
$25.64
1-Week Range:
$22.25
$25.64
52-Week Range:
$7.84
$25.64
Brainsway Ltd Adr Stock (BWAY) Company Profile
Compare BWAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
25.46 | 483.96M | 38.63M | 1.50M | 5.97M | 0.0943 |
|
ABT
Abbott Laboratories
|
107.08 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.22 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.58 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.31 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.78 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-03-22 | Initiated | Loop Capital | Buy |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | Northland Capital | Outperform |
| May-13-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-13-19 | Initiated | Ladenburg Thalmann | Buy |
| May-13-19 | Initiated | Oppenheimer | Outperform |
| May-13-19 | Initiated | Raymond James | Outperform |
View All
Brainsway Ltd Adr Stock (BWAY) Latest News
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Northland Securities Predicts Brainsway Q3 Earnings - MarketBeat
Northland Securities Estimates Brainsway Q1 Earnings - MarketBeat
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Down 21.1% in December - MarketBeat
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - sharewise.com
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) - Chartmill
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™ - Chartmill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Update - MarketBeat
Investment Analysts’ Weekly Ratings Updates for Brainsway (BWAY) - Defense World
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens - Eastern Progress
Are Options Traders Betting on a Big Move in BrainsWay Stock? - sharewise.com
BrainsWay Ltd. (NASDAQ:BWAY) Expanding Reach In Mental Health Care - Kalkine Media
FY2025 EPS Estimate for Brainsway Decreased by Analyst - Defense World
Northland Capmk Reduces Earnings Estimates for Brainsway - MarketBeat
Northland Capmk Predicts Weaker Earnings for Brainsway - Defense World
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewswire Inc.
Brainsway (NASDAQ:BWAY) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Brainsway (BWAY) Projected to Post Earnings on Tuesday - Defense World
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? - sharewise.com
HC Wainwright Has Bearish Forecast for Brainsway Q4 Earnings - MarketBeat
BrainsWay secures two more U.S. mental health provider investments By Investing.com - Investing.com
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - sharewise.com
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy - The Globe and Mail
Brainsway (NASDAQ:BWAY) Shares Up 1.9%Here's What Happened - MarketBeat
Do Options Traders Know Something About Brainsway Stock We Don't? - sharewise.com
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Increase in Short Interest - MarketBeat
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care - sharewise.com
Insider Trading At ESS Tech Inc (NYSE: GWH): What Did We Note? - stocksregister.com
Why Buying The Brainsway Ltd ADR (NASDAQ: BWAY) Stock Today Might Make Sense - stocksregister.com
Is Robo.ai Inc (NASDAQ: AIIO) Stock Good For Medium-Term Investing? - stocksregister.com
Acadian Asset Management LLC Decreases Holdings in Brainsway Ltd. Sponsored ADR $BWAY - Defense World
Brainsway stock surges after FDA clears accelerated depression treatment - Investing.com
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Declines By 20.1% - MarketBeat
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Up 191.8% in August - Defense World
Trexquant Investment LP Takes $129,000 Position in Brainsway Ltd. Sponsored ADR $BWAY - Defense World
Brainsway Ltd. Sponsored ADR $BWAY Shares Sold by DAFNA Capital Management LLC - MarketBeat
Brainsway’s (BWAY) Buy Rating Reaffirmed at HC Wainwright - Defense World
Brainsway stock maintains Buy rating at H.C. Wainwright after strategic investments By Investing.com - Investing.com
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care - sharewise.com
Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay - Barchart.com
Brainsway Ltd Adr Stock (BWAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):